# Kato Pharmaceuticals, Inc. — Form D

Kato Pharmaceuticals, Inc. of LAGUNA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-26. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-10-26
- Form: D
- Accession: 0001382963-18-000137
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 9
- Date of first sale: 2018-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-324435

## Issuer

- Name: Kato Pharmaceuticals, Inc.
- CIK: 0001756482
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 26051 MERIT CIRCLE, LAGUNA HILLS, CA, 92653
- Phone: (949) 348-1188

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Olav B Berghein | Director | Laguna Hills, CA |
| Mauro B Bove | Director | Laguna Hills, CA |
| Terrance S McGovern | Director | Laguna Hills, CA |
| Terrance S McGovern | Executive Officer | Laguna Hills, CA |
| Hugh S Neuharth | Executive Officer | Laguna Hills, CA |

## More

- [CIK 1756482 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1756482&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001382963-18-000137.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.